Scientific Meeting

科学会议

• 批准号: 7251414
• 负责人: CATHERINE M VERFAILLIE
• 金额: $ 0.5万
• 依托单位: INTERNATIONAL SOCIETY/EXPER HEMATOLOGY
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-09-26 至 2007-08-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7251414
• 关键词: biological products; hematology; meeting /conference /symposium; stem cell transplantation; travel

DESCRIPTION (provided by applicant): Use of stem cells as a therapeutic modality has great potential beyond that currently implemented for patients with inherited or acquired hematologic disorders. However, little is known regarding the manufacturing of stem cells from an industry perspective, GMP procedures that will be required for a stem cell product, methods to infuse the cells and have them home properly to the tissue in need of repair, the impact of aging on stem cells used as a therapeutic, ways to manipulate leukemic stem cells via their environment, and the response of patients to the transplanted cells (or the graft to the host). This ISEH program will bring together experts in each of these areas to present the most recent information to the physicians, scientists, and industry personnel in attendance.

描述（由申请人提供）： 干细胞作为一种治疗方式的使用具有超越目前实施的巨大潜力 用于遗传性或获得性血液病患者。然而，从工业角度来看，关于干细胞的制造知之甚少，干细胞产品所需的GMP程序，注入细胞并使它们正确地回到需要修复的组织的方法，衰老对用作治疗剂的干细胞的影响，通过其环境操纵白血病干细胞的方法，以及患者对移植细胞（或移植物对宿主）的反应。该ISEH计划将汇集这些领域的专家，向出席会议的医生，科学家和行业人员提供最新信息。